AbbVie’s immunology blockbusters make up for Humira sales drop in Q3

AbbVie is lifting its profit outlook and full-year 2024 guidance as its immunology blockbusters Skyrizi and Rinvoq beat quarterly revenue estimates, according to the company …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Scientists identify a new approach to treating sarcoidosis

A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis.

January 23, 2024

Global CNS Therapeutics Strategic Report 2023: Market to Reach $199 Billion by 2030 – Developing Market to Drive the Market Momentum, Asia-Pacific to Exhibit Fastest Growth | Psychedelic Invest

The “CNS Therapeutics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global CNS Therapeutics Market to Reach $199 Billion by 2030 The global market for

November 30, 2023

Tenpoint raises funds to develop cell therapies for vision loss

The company will develop a regenerative medicine platform that could substitute multiple types of cells destroyed by inherited and age-linked ocular ailments. Credit: wavebreakmedia /

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.